Hudson Bay Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,261,609
| Closed | -$12.7M | – | 1138 |
|
|
2022
Q4 | $12.7M | Hold |
1,261,609
| – | – | 0.13% | 115 |
|
|
2022
Q3 | $12.5M | Hold |
1,261,609
| – | – | 0.11% | 108 |
|
|
2022
Q2 | $12.5M | Buy |
1,261,609
+751,824
| +147% | +$7.44M | 0.09% | 116 |
|
|
2022
Q1 | $5.02M | Buy |
509,785
+18,159
| +4% | +$179K | 0.07% | 346 |
|
|
2021
Q4 | $4.84M | Buy |
491,626
+101,696
| +26% | +$1M | 0.05% | 343 |
|
|
2021
Q3 | $3.8M | Hold |
389,930
| – | – | 0.05% | 432 |
|
|
2021
Q2 | $3.77M | Buy |
389,930
+189,930
| +95% | +$1.84M | 0.05% | 420 |
|
|
2021
Q1 | $1.94M | Buy |
+200,000
| New | +$1.94M | 0.02% | 562 |
|